Table 1.
Characteristics | Before ULT | After ULT | P-value | |
---|---|---|---|---|
Paired t-test | t-test | |||
Male sex, n (%) | 26 (100%) | |||
Presence of intra-articular tophi, n (%) | 26 (100%) | |||
Subcutaneous tophi over knee, n (%) | 16 (61.5%) | |||
Age at initial visit (yr) | 48.4 ± 9.8 | |||
Age at gout onset (yr) | 33.2 ± 10.2 | |||
Age of tophi onset (yr) | 40.3 ± 9.9 | |||
Subcutaneous tophi duration (yr) | 8.7 ± 6.2 | |||
Difficulty in squatting (yr), n = 23 | 4.7 ± 3.7 | |||
Total subcutaneous tophi (cm) | 52.8 ± 40.5 | 8.1 ± 12.5 | <0.001 | <0.001 |
Total intra-articular tophi (cm) | 18.0 ± 9.5 | 8.2 ± 4.7 | <0.001 | <0.001 |
Knee joint range of motion (degree) | 103.5 ± 5.7 | 129.6 ± 6.5 | <0.001 | <0.001 |
Comparison before and 18.2 months (standard deviation [SD]: 5.9 months) after urate-lowering therapy (ULT).
Data are expressed as mean ± standard deviation or number (percentage), p < 0.05 considered significant.